查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1800248

全球气道支架市场：2025 年至 2030 年预测

Global Airway Stent Market - Forecasts fom 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 148 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计气道支架市场将从 2025 年的 141,017,000 美元增长到 2030 年的 181,331,000 美元，复合年增长率为 5.16%。

由于慢性呼吸系统疾病的盛行率不断上升以及微创手术的日益普及，预计气道支架市场将在2025年至2030年间大幅成长。气道支架用于透过机械清创、雷射消融、动态疗法和支气管内近距离放射治疗等手术来治疗中央气道的良性和恶性病变，并且是治疗肺癌、结核病和慢性阻塞性肺病(COPD) 等疾病的关键。生物分解性支架和药物释放型支架的进步、污染水平的上升以及吸烟率的居高不下推动了气道支架市场的发展。北美引领市场，而亚太地区则显示出巨大的成长潜力。挑战包括与支架置入相关的併发症。

市场驱动因素

呼吸系统疾病盛行率上升

肺癌、结核病和慢性阻塞性肺病 (COPD) 等慢性呼吸系统疾病发生率的不断上升是气道支架市场的主要驱动力。全球污染水平的上升和持续的高吸烟率加剧了这些疾病的负担。气道支架对于维持阻塞性病变患者的气道通畅性以及支持性治疗和安宁疗护至关重要。对有效干预措施来管理这些疾病的需求日益增长，这推动了对先进支架技术的需求。

偏好微创治疗

与传统手术相比，微创手术恢復时间更快、併发症风险更低，因此人们日益偏好微创手术，推动了气道支架的普及。内视镜支架置入等治疗技术能精准治疗气道阻塞，改善患者预后。这一趋势在医院和门诊手术中心尤为明显，微创手术越来越多地被纳入标准治疗通讯协定，进一步推动了市场成长。

支架技术的进步

生物分解性和药物释放型气道支架的技术创新正在推动市场成长。生物分解性支架无需移除手术，并可减少长期併发症；而药物释放型支架则提供标靶治疗，可预防血管再阻塞和发炎。这些进步正在改善患者安全性和治疗效果，促进临床应用，并支持市场扩张。

市场限制

气道支架市场面临挑战，因为支架置入相关併发症（例如移位、感染和肉芽组织形成）可能会阻碍其推广应用并增加医疗成本。先进支架的高昂成本以及对熟练专业人员进行内视镜手术的需求也构成了障碍，尤其是在医疗基础设施有限的发展中地区。透过改进支架设计和培训专案来应对这些挑战，对于市场的持续成长至关重要。

目录

第一章执行摘要

第二章市场概述

  • 市场概览
  • 市场定义
  • 调查范围
  • 市场区隔

第三章 经营状况

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策法规
  • 策略建议

第四章 技术展望

5. 全球气道支架市场（依材料类型）

  • 介绍
  • 金属
  • 硅酮
  • 杂交种

6. 全球气道支架市场（依最终用户）

  • 介绍
  • 医院和诊所
  • 门诊手术中心

7. 全球气道支架市场（按地区）

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 其他的
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 印尼
    • 泰国
    • 其他的

第八章竞争格局及分析

  • 主要企业和策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 竞争对手仪表板

第九章：公司简介

  • Boston Scientific Corporation
  • Novatech SA
  • Cook Medical
  • MICRO-TECH Europe GmbH
  • Medtronic
  • Cook Medical
  • MICRO-TECH（Nanjing）Co., Ltd.
  • Merit Medical Systems

第十章调查方法

简介目录
Product Code: KSI061612095

The global airway stent market is expected to grow from USD 141.017 million in 2025 to USD 181.331 million in 2030, at a CAGR of 5.16%.

The global airway stent market is projected to experience significant growth from 2025 to 2030, driven by the rising prevalence of respiratory chronic disorders and the increasing adoption of minimally invasive procedures. Airway stents, used to manage benign and malignant lesions in the central airway through techniques like mechanical debridement, laser resection, photodynamic therapy, and endobronchial brachytherapy, are critical for treating conditions such as lung cancer, tuberculosis, and chronic obstructive pulmonary disease (COPD). The market is propelled by advancements in biodegradable and drug-eluting stents, rising pollution levels, and high tobacco smoking rates. North America leads the market, while Asia-Pacific shows strong growth potential. Challenges include complications associated with stent implantation.

Market Drivers

Rising Prevalence of Respiratory Disorders

The increasing incidence of chronic respiratory conditions, including lung cancer, tuberculosis, and COPD, is a primary driver of the airway stent market. Rising pollution levels and the persistent high prevalence of tobacco smoking globally contribute to the growing burden of these diseases. Airway stents are essential for maintaining airway patency in patients with obstructive lesions, supporting both therapeutic and palliative care. The escalating need for effective interventions to manage these conditions is driving demand for advanced stent technologies.

Preference for Minimally Invasive Procedures

The growing preference for minimally invasive procedures, which offer reduced recovery times and lower complication risks compared to traditional surgeries, is boosting the adoption of airway stents. Techniques like endoscopic stent placement enable precise treatment of airway obstructions, improving patient outcomes. This trend is particularly prominent in hospitals and ambulatory surgical centers, where minimally invasive approaches are increasingly integrated into standard care protocols, further fueling market growth.

Advancements in Stent Technology

Innovations in biodegradable and drug-eluting airway stents are enhancing market growth. Biodegradable stents eliminate the need for removal procedures, reducing long-term complications, while drug-eluting stents deliver targeted therapies to prevent restenosis and inflammation. These advancements improve patient safety and treatment efficacy, driving adoption across clinical settings and supporting the market's expansion.

Market Restraints

The airway stent market faces challenges due to complications associated with stent implantation, such as migration, infection, or granulation tissue formation, which can deter adoption and increase healthcare costs. The high cost of advanced stents and the need for skilled professionals to perform endoscopic procedures also pose barriers, particularly in developing regions with limited healthcare infrastructure. Addressing these challenges through improved stent designs and training programs will be critical for sustained market growth.

Market Segmentation

By Material Type

The market is segmented into metal, silicone, and hybrid stents. Silicone stents dominate due to their flexibility and biocompatibility, making them suitable for long-term use in benign conditions. Metal stents are preferred for malignant obstructions due to their durability, while hybrid stents, combining metal and silicone properties, are gaining traction for their versatility in complex cases.

By End-User

The market is divided into hospitals and clinics, and ambulatory surgical centers. Hospitals and clinics hold the largest share, driven by their advanced infrastructure and high volume of respiratory procedures. Ambulatory surgical centers are a growing segment, supported by the increasing adoption of minimally invasive techniques in outpatient settings.

By Geography

The market is segmented into North America, Europe, Asia-Pacific, South America, and the Middle East and Africa. North America leads due to its advanced healthcare systems, high prevalence of respiratory disorders, and early adoption of innovative stent technologies. Asia-Pacific is expected to grow rapidly, driven by increasing healthcare investments, rising pollution levels, and growing awareness of respiratory health in countries like China and India. Europe, South America, and the Middle East and Africa are emerging markets, supported by improving healthcare infrastructure.

The airway stent market is set for robust growth from 2025 to 2030, driven by the rising prevalence of respiratory disorders, preference for minimally invasive procedures, and advancements in biodegradable and drug-eluting stents. Despite challenges from implantation complications and high costs, the market's outlook is positive, particularly in North America and Asia-Pacific. Industry players must focus on innovative stent designs, cost-effective solutions, and clinician training to capitalize on the growing demand for airway stents in managing chronic respiratory conditions.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2020 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Different segments covered under the global airway stent market report are as below:

By Material Type

  • Metal
  • Silicone
  • Hybrid

By End-User

  • Hospitals and Clinics
  • Ambulatory Surgical Centers

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL AIRWAY STENT MARKET BY MATERIAL TYPE

  • 5.1. Introduction
  • 5.2. Metal
  • 5.3. Silicone
  • 5.4. Hybrid

6. GLOBAL AIRWAY STENT MARKET BY END-USER

  • 6.1. Introduction
  • 6.2. Hospitals and Clinics
  • 6.3. Ambulatory Surgical Centers

7. GLOBAL AIRWAY STENT MARKET BY GEOGRAPHY

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. USA
    • 7.2.2. Canada
    • 7.2.3. Mexico
  • 7.3. South America
    • 7.3.1. Brazil
    • 7.3.2. Argentina
    • 7.3.3. Others
  • 7.4. Europe
    • 7.4.1. United Kingdom
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Spain
    • 7.4.5. Others
  • 7.5. Middle East & Africa
    • 7.5.1. Saudi Arabia
    • 7.5.2. UAE
    • 7.5.3. Israel
    • 7.5.4. Others
  • 7.6. Asia Pacific
    • 7.6.1. Japan
    • 7.6.2. China
    • 7.6.3. India
    • 7.6.4. South Korea
    • 7.6.5. Indonesia
    • 7.6.6. Thailand
    • 7.6.7. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Market Share Analysis
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 8.4. Competitive Dashboard

9. COMPANY PROFILES

  • 9.1. Boston Scientific Corporation
  • 9.2. Novatech SA
  • 9.3. Cook Medical
  • 9.4. MICRO-TECH Europe GmbH
  • 9.5. Medtronic
  • 9.6. Cook Medical
  • 9.7. MICRO-TECH (Nanjing) Co., Ltd.
  • 9.8. Merit Medical Systems

10. RESEARCH METHODOLOGY